Oxford PharmaGenesis Inc. celebrates its third consecutive year as a Great Place to Work®
Oxford PharmaGenesis Inc. has been named as a Great Place to Work® for the third consecutive year!
Featured
24 January 2024
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
All
- All
- News
- Articles
- Events
Open Pharma and Oxford PharmaGenesis at the latest MedComms Brunch Club
At the October meeting of the MedComms Brunch Club in Oxford, employees of Oxford PharmaGenesis used this year’s Open Access Week as an opportunity to launch the Open Pharma position statement on open access and to present Oxford PharmaGenesis-funded research on open access, clinical trial transparency and the role of professional medical writing support.
Bridging the gap in communications at the Patient Summit Europe 2019
Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit Europe in London.
ISMPP Asia-Pacific joins the push for open science in pharma
Oxford PharmaGenesis was in Tokyo to see ‘open science’ take centre stage at the 2019 Asia-Pacific Meeting of ISMPP
Oxford consultancy receives second royal honour for international trade
Lord Lieutenant leads celebrations at global Oxford-based consultancy
Professional medical writers improve the quality and speed of clinical trial reporting
A systematic review of the impact of professional medical writing support on the quality, ethics and timeliness of clinical trial reporting has been published in Research Integrity and Peer Review.
